How Biotech Can Succeed Outside the Hubs
Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.
Clearside Biomedical's SWOT analysis: innovative eye treatment stock faces pivotal trial
Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...
News Medical2d
New gut-on-chip model could revolutionize immunotherapy for melanoma
A team of researchers from the European Institute of Oncology and the Politecnico di Milano, coordinated by Luigi Nezi, Team ...
Leg muscle may serve as an early warning system for heart failure, study finds
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...
'Gut-on-chip' can predict immunotherapy outcomes for melanoma patients
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...
Mouse model unveils dynamics through which SYNGAP1 gene supports cognitive function
The SYNGAP1 gene, which supports the production of a protein called SynGAP (Synaptic Ras GTPase-Activating Protein), is known ...